Mostrar el registro sencillo del ítem
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group
dc.contributor.author | Guirado, M. | |
dc.contributor.author | Sanchez-Hernandez, A. | |
dc.contributor.author | Pijuan, L. | |
dc.contributor.author | Teixido, C. | |
dc.contributor.author | Gómez Caamaño, Antonio | |
dc.contributor.author | Cilleruelo-Ramos, Á | |
dc.date.accessioned | 2024-01-02T10:04:57Z | |
dc.date.available | 2024-01-02T10:04:57Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1699-048X | |
dc.identifier.other | https://www.ncbi.nlm.nih.gov/pubmed/34665437 | es |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/18528 | |
dc.description.abstract | Multidisciplinary care is needed to decide the best therapeutic approach and to provide optimal care to patients with lung cancer (LC). Multidisciplinary teams (MDTs) are optimal strategies for the management of patients with LC and have been associated with better outcomes, such as an increase in quality of life and survival. The Spanish Lung Cancer Group has promoted this review about the current situation of the existing national LC-MDTs, which also offers a set of excellence requirements and quality indicators to achieve the best care in any patient with LC. Time and sufficient resources; leadership; administrative and institutional support; and recording of activity are key factors for the success of LC-MDTs. A set of excellence requirements in terms of staff, resources and organization of the LC-MDT have been proposed. At last, a list of quality indicators has been agreed to achieve and measure the performance of current LC-MDTs. | |
dc.language.iso | en | |
dc.rights | Atribución 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.title | Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group | |
dc.type | Journal Article | es |
dc.authorsophos | Guirado, M.;Sanchez-Hernandez, A.;Pijuan, L.;Teixido, C.;Gómez-Caamaño, A.;Cilleruelo-Ramos, Á | |
dc.identifier.doi | 10.1007/s12094-021-02712-8 | |
dc.identifier.pmid | 34665437 | |
dc.identifier.sophos | 43988 | |
dc.issue.number | 3 | |
dc.journal.title | Clinical & Translational Oncology | |
dc.organization | Servizo Galego de Saúde::Áreas Sanitarias (A.S.)::Área Sanitaria de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Oncoloxía Radioterápica | |
dc.rights.accessRights | openAccess | |
dc.subject.keyword | Área Sanitaria de Santiago de Compostela e Barbanza | es |
dc.typefides | Artículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis) | es |
dc.typesophos | Artículo de Revisión | es |
dc.volume.number | 24 |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
![](/xmlui/themes/Mirage2//images/final_lines.png)